Clinical trial
Effectiveness of Zoledronic Acid in the Prevention of Osteoporosis in Early…
NCT00376740 · Soroka University Medical Center, Other · Completed
Key facts
| NCT number | NCT00376740 |
|---|---|
| Title | Effectiveness of Zoledronic Acid in the Prevention of Osteoporosis in Early Breast Cancer Patients Receiving Letrozole |
| Official title | Phase 3 Study of the Effect of Zoledronic Acid in the Prevention of Osteoporosis in Early Breast Cancer Patients Receiving the Aromatase Inhibitor, Letrozole, in the Adjuvant Setting |
| Lead sponsor | Soroka University Medical Center, Other |
| Collaborators | Tel-Aviv Sourasky Medical Center |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | zoledronic acid |
| Enrollment | 90 |
| Start date | Sep 1, 2005 |
| Primary completion | Nov 1, 2010 |
| First posted | Sep 15, 2006 |
| Last update posted | Aug 23, 2011 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: